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andomized trials and 
observational studies have 
conclusively shown a marked 
improvement in several cardiovascular 
risk factors when obese individuals lose 
weight, including decreases in blood 
pressure, and improvements in the 
lipid proﬁ  le and glucose metabolism. 
These results are closely consistent with 
observational data linking weight gain 
to worsening of these cardiovascular 
risk factors, and to their natural 
sequelae, clinical cardiovascular events. 
Obesity is also strongly associated with 
increased risk of cancer at various 
sites. With such compelling evidence 
of the adverse effects of obesity and 
overweight [1–4], why has there been 
a continuing controversy about its 
association with overall mortality? 
In their paper in this month’s PLoS 
Medicine, Jaakio Kaprio and colleagues 
conclude that “deliberate weight loss 
in overweight subjects without known 
co-morbidities may be hazardous 
in the long term” [5]. Do the data 
really support such a conclusion? An 
examination of this paper illustrates 
several of the complexities in 
approaching this seemingly simple 
question. 
Evidence from Epidemiological 
Studies
Epidemiologic studies of the 
relation between overweight and 
mortality typically must address three 
principal concerns [6]. First, in 
many populations, cigarette smokers 
tend to be leaner than nonsmokers. 
Because cigarette smoking is such 
a strong risk factor for mortality, 
failure to adjust for this adequately 
can lead to confounding, with the 
erroneous conclusion that leanness 
carries increased risk of death. 
Statistical adjustment for smoking is 
often insufﬁ  cient to account for this 
difﬁ  culty. Smoking can lead to medical 
conditions, sometimes sub-clinical, that 
are associated with decreased body 
weight, such as chronic obstructive 
pulmonary disease. The presence of 
symptoms or diagnosed conditions 
may induce smokers to quit. Moreover, 
the intensity of smoking is related 
to both risk of death and body mass 
index. For these reasons, the best way 
to assess the impact of overweight on 
risk of mortality is simply to exclude 
current and past smokers. Kaprio 
and colleagues’ study differentiated 
only current smoker or nonsmoker. 
Thus, never-smokers were included 
in the same category as past smokers, 
regardless of how much the past 
smokers had smoked or their reasons 
for quitting.
A second difﬁ  culty in some 
epidemiologic studies is the inclusion 
of intermediary factors as co-variates. 
Weight loss improves hypertension 
and diabetes, so including these as 
co-variates would tend to attenuate 
the apparent beneﬁ  t of weight loss. 
In the present study, the authors 
appropriately excluded people 
with diabetes, and adjustment for 
hypertension appeared to have little 
impact.  
The third and most difﬁ  cult issue in 
studies of overweight and mortality is 
reverse causation, the impact of disease 
on body weight. This can occur either 
through the biological impact of a 
condition (diagnosed or preclinical) 
or as an inducement to attempt to lose 
weight as a means to improve health. 
The authors’ keen recognition of this 
problem provides a signiﬁ  cant strength 
to the present study. The authors 
appropriately excluded individuals 
with a wide range of conditions to 
identify an apparently healthy cohort. 
This critical step is often ignored. 
Sometimes, investigators also exclude 
deaths that occur in the ﬁ  rst few years 
after follow-up, to reduce the impact of 
reverse causation. Such lagged analyses 
can be helpful, but some chronic 
conditions of long duration, such as 
depression, chronic lung disease, and 
heart failure (conditions that often may 
not reach the level of clinical diagnosis) 
can lead to lower body weight and 
higher mortality risk. Hence, that 
strategy (not employed by Kaprio and 
colleagues) may not fully avoid the 
problem.
The Difﬁ  culties of Assessing the 
Effects of Intention to Lose Weight
As a further step toward reducing the 
potential bias of the impact of disease 
on body weight, the authors identiﬁ  ed 
individuals with intent to lose weight. 
Unintended weight loss is well known 
as an ominous clinical sign, usually 
signifying a serious illness. Just over a 
third of the overweight subjects in the 
Kaprio cohort had expressed intent 
to lose weight at baseline in 1975. It 
is interesting to note that despite this 
intention, as a group, the median 
weight change in the ensuing six 
years was a gain of 0.33 kg/m2, almost 
identical to the weight change in the 
group that had not expressed intent to 
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lose weight (gain of 0.31 kg/m2). Thus, 
this study cannot fairly be characterized 
as an assessment of intentional 
weight loss and its subsequent effect 
on mortality. Because the changes 
in weight are so similar in these two 
groups, it is implausible to attribute 
the weight loss in the intent-to-lose 
group to that intention. These ﬁ  ndings 
render the results particularly difﬁ  cult 
to interpret. 
Other important limitations 
include the very small number of 
endpoints—only 268 total deaths in 
the cohort. When further subdivided 
according to intention to lose weight, 
and categories of weight change, the 
numbers are far from sufﬁ  cient for 
reliable estimates. For example, the 
main conclusions are based on the 
subgroup of those with intent to lose 
weight who actually lost weight; this 
group had only 42 deaths, of which ten 
were violent. Another related difﬁ  culty 
is that this cohort, though overweight, 
is not drastically obese. The median 
body mass index (BMI) was 26.7 kg/
m2, and fewer than 10% of people had 
a BMI greater than 30. With such a 
narrow range of BMI, coupled with the 
very small changes in weight during 
the six years of initial follow-up, even 
a very large study would not have 
sufﬁ  cient power to detect plausible 
relative risks associated with weight 
change. 
What Advice Should Be Given?
Given the well-known adverse 
metabolic consequences of overweight 
and obesity, the strong links with 
cardiovascular disease and several 
other serious illnesses, and the absence 
of any plausible adverse biologic 
consequences of maintaining normal 
weight (BMI 19 to 25), it seems 
prudent to continue advising adults to 
seek to maintain a weight within that 
range. The results from Kaprio et al, 
although they raise questions about 
the effects of weight loss, do not cast 
serious doubt on that advice.  
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